The present invention relates to the field of programmable medical devices. More particularly, this invention relates to a management system for medical devices that have at least one parameter that is programmable based upon at least one characteristic of a patient.
Implantable medical devices are commonly used for treating various medical conditions, many of which relate to the heart. For example, cardiac rhythm management (CRM) implantable devices are often implanted in patients to deliver therapy to the heart. CRM implantable devices include, for example, cardiac pacemakers or “pacers”. Pacers deliver timed sequences of low energy electrical stimuli, called “pace pulses”, to the heart via an intra vascular leadwire or catheter (referred to as a “lead”) having one or more electrodes disposed in or about the heart. The pace pulses initiate heart contractions in a process called “capturing” the heart. By properly timing the delivery of the pace pulses, a heart with an irregular cardiac rhythm (i.e., a cardiac arrhythmia) can be induced to contract with a proper rhythm, thereby improving its efficiency as a pump. Pacers are often used to treat patients with bradyarrhythmias (i.e., hearts that beat too slowly, or beat irregularly).
CRM implantable devices also include cardioverters or defibrillators that are capable of delivering higher energy electrical stimuli to the heart. Defibrillators are often used to treat patients with tachyarrhythmias (i.e., hearts that beat too quickly). Such too-fast heart rhythms can cause the heart to pump inefficiently since the heart is not allowed sufficient time to fill with blood before contracting to expel the blood. A defibrillator is capable of delivering a high energy electrical stimulus that is sometimes referred to as a “defibrillation countershock”. The countershock interrupts the tachyarrhythmia to allow the heart to re-establish a normal rhythm for efficiently pumping the blood. Still other types of CRM implantable devices include, for example, pacer/defibrillators that combine the functions of both pacers and defibrillators, drug delivery devices, or any other implantable medical devices that are used for diagnosing and/or treating cardiac arrhythmias.
CRM implantable devices are often capable of delivering therapy to the heart of a patient in a manner that depends on one or more parameters that can be set or adjusted by the patient's physician. For example, a pacer may have programmable parameters such as atrioventricular (AV) delay (i.e., the length of time between an atrial sensed or atrial paced event and the delivery of a ventricular output pulse), an LV offset (i.e., the length of time between a sensed or paced event in a first ventricle and the delivery of an output pulse to a second ventricle), a target heart rate, whether or not to turn on rate smoothing, smoothing percentage for increasing rate, smoothing percentage for decreasing rate, etc. The programmable parameters depend on the particular CRM implantable device, and are typically intended to be programmed based upon the physician's evaluation of the patient.
The primary clinical tool that allows a physician to set or update programmable parameters of a CRM implantable device is a medical device programmer. Such medical device programmers often use inductive coils to provide bidirectional telemetry between the programmer and the implantable device. By using such a programmer, a physician can receive and view stored cardiac and system data from the implantable device, and can send programming instructions back down to the implantable device. Thus, programmers allow physicians to set or adjust the programmable parameters of implantable medical devices.
As additional therapeutic features are introduced into CRM implantable devices, programming such devices to provide optimal therapy for a particular patient has become an increasingly complicated task for medical practitioners. For example, many medical practitioners who may implant only a few devices per year do not have the time nor the resources that would be needed to optimally program such devices. Even practitioners more familiar with such devices, such as physicians who perform perhaps 50 implants per year and who may know how to create custom profiles for particular classes of patients for particular devices, typically do not have the time nor the resources to stay current with each new development in the field. Such problems are likely to worsen as the number of different types of implantable devices increases, and as each type of implantable device becomes more complex. As a result of such problems, many if not most practitioners use only the factory-set, default parameters of CRM implantable devices, while other medical practitioners may adjust only a subset of the parameters from the factory-set parameters. While using default parameters may provide adequate therapy for a generalized class of patients, the use of such parameters often does not provide optimal therapy for a particular patient.
Thus, even though medical device programmers give medical practitioners the capability to set or update the programmable parameters of CRM implantable devices, the medical practitioners often lack the resources and the knowledge that would be needed to optimally program such devices to provide optimal therapy for particular patients. This problem is likely to worsen as new types of CRM implantable devices are developed, and as new and additional features are added to new and existing CRM implantable devices. As a result, the therapeutic benefits of such devices may not reach their full potential.
Therefore, it would be advantageous to provide an improved system and method for programming CRM implantable medical devices that solves these and other problems.
In accordance with one aspect of the present invention, a centralized management system for medical devices includes a network, a central server coupled to the network, and a medical device programmer also coupled to the network. The central server includes at least one prescription system for prescribing at least one programmable parameter of a medical device based upon at least one characteristic of a patient. The medical device programmer communicates at least one characteristic of a patient to the central server via the network, receives at least one programmable parameter from the central server via the network, and programs the medical device using the at least one programmable parameter.
In accordance with another aspect of the present invention, a central server for use in a centralized management system for medical devices includes a network interface for communicating with a medical device programmer over a network, and at least one prescription system coupled to the network interface. Each prescription system is able to receive at least one characteristic of a patient from the medical device programmer via the network, to prescribe at least one programmable parameter of a medical device based upon the at least one characteristic of the patient, and to transmit the at least one prescribed programmable parameter to the medical device programmer via the network.
In accordance with another aspect of the invention, a medical device programmer for use in a centralized management system for medical devices includes a network interface for communicating with a central server over a network, a medical device interface for communicating with a medical device, and a processor coupled to the network interface and the medical device interface. The processor communicates at least one characteristic of a patient to the central server via the network, receives at least one prescribed parameter of the medical device from the central server via the network, and programs the medical device using the at least one prescribed parameter via the medical device interface.
In accordance with another aspect of the present invention, a method of programming a programmable medical device includes determining at least one characteristic of a patient at a medical device programmer, communicating the at least one characteristic to a central server, determining at least one programmable parameter for a medical device based upon the at least one characteristic using a prescription system hosted by the central server, communicating the at least one programmable parameter to the medical device programmer, and programming the medical device using the at least one programmable parameter.
These and various other features as well as advantages which characterize the present invention will be apparent to a person of ordinary skill in the art upon reading the following detailed description and reviewing the associated drawings.
In the following detailed description, reference is made to the accompanying drawings, which form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. In the drawings, like numerals refer to like components throughout the views. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is to be understood that the embodiments may be combined, or that other embodiments may be utilized and that structural, logical and electrical changes may be made without departing from the spirit and scope of the invention. The following description is, therefore, not to be taken in a limiting sense, and the scope of the invention is defined by the appended claims and their equivalents.
Referring to
In one embodiment, network 102 is a wide area network (WAN) that allows for bidirectional communications to occur over a wide geographic area. For example, network 102 may include point-to-point unswitched private communication lines such as T1 or T3 lines, or switched lines like those of the public switched telephone network (PSTN), ISDN lines, etc. For another example, network 102 includes the Internet. Using a WAN eliminates or reduces any geographic restrictions placed on the locations of central server 104, medical device programmer(s) 106, and expert client(s) 108, and any two of these components can be physically located close to one another, far from one another, or any distance in between. In various embodiments, the communications between central server 104, programmer(s) 106 and expert client(s) 108 takes place over an electrical, optical, radio-frequency (RF), or wireless communication medium, or a combination of such communication mediums.
In another embodiment, network 102 is a local area network (LAN) that allows for communications to occur over a local geographic area, such as within a building or complex. For example, network 102 may include an Ethernet or token ring network in a hospital or hospital complex. In yet another embodiment, network 102 is a metropolitan area network (MAN) generally covering a metropolitan geographic area such as a city, town or county.
Central server 104 hosts at least one prescription system for prescribing at least one programmable parameter of a medical device based on at least one characteristic of a patient. The at least one patient characteristic is received by central server 104 from any of the medical device programmers 106 via network 102, and the at least one prescribed programmable parameter is then transmitted back to that programmer via network 102 for use in programming a medical device that will provide therapy for the patient. Thus, by executing a prescription system, central server 104 is capable of prescribing one or more programmable parameters for a medical device based upon at least one characteristic of a patient. In one embodiment, central server 104 includes a computer system and software that are dedicated to hosting the at least one prescription system. In another embodiment, central server 104 includes software that executes on a computer system that runs other applications. Central server 104 may thus include a combination of hardware and software, or software only. Central server 104, and its operation in system 100, is described further below.
Each medical device programmer 106 communicates at least one characteristic of a patient to central server 104 via network 102, and receives at least one prescribed programmable parameter of a medical device from central server 104 via network 102. Each medical device programmer 106 receives the at least one characteristic from any or all of a number of different sources (described below), and uses the at least one prescribed parameter to program an implantable medical device 110 coupled to the programmer 106. Each medical device programmer 106, and its operation in system 100, is described further below.
As illustrated in
In another embodiment, any or all of medical device programmers 106 is coupled to, and is capable of programming, another type of implantable medical device that is programmed according to the individual characteristics of the patient, but is not used to diagnose or treat cardiac arrhythmias. For example, any or all of programmers 106 may be coupled to, and be capable of programming, an implantable drug delivery device that is not used for CRM purposes. In yet another embodiment, any or all of programmers 106 is coupled to, and is capable of programming, a non-implantable medical device that is programmed according to the individual characteristics of the patient. For example, any or all of programmers 106 may be coupled to, and be capable of programming, an external pacer that is disposed on the chest of a patient in order to deliver therapeutic pace pulses.
In one embodiment, centralized management system 100 is capable of programming just one type of medical device. For example, system 100 could be capable of programming only a particular type of pacer. In another embodiment, system 100 can program more than one type of medical device. In this embodiment, any of multiple types of medical devices can be programmed using any of medical device programmers 106. For example, a practitioner equipped with a programmer 106 can use central server 104 to prescribe a first set of programming parameters to program a pacer for a first patient, and a second set of programming parameters to program a defibrillator (or another type of pacer) for a second patient. In one embodiment, programmer 106 identifies the type of medical device being programmed (e.g., from a user input), and transmits that information to the central server.
Note that a CRM or non-CRM implantable medical device is programmable by an appropriate medical device programmer 106 regardless of whether or not that device has actually been implanted into the body of a patient. For example, an implantable pacer can be programmed before that pacer is implanted into the body of a patient, and can also be programmed when that pacer is outside the body (e.g., before being implanted). Thus, an “implantable” medical device refers to a medical device that is capable of being implanted into the body of a patient, regardless of whether or not that device is actually implanted.
In the embodiment of
In another embodiment, system 100 does not include any expert clients 108. In such an embodiment, information representing each expert's knowledge and skills may be entered directly into central server 104 to define or update the prescription system of that expert. For example, an expert could develop an expert system offline, and that expert system could be loaded onto central server 104 using a magnetic or optical disc, or other medium for data exchange. Alternatively, if central server 104 does not include any expert prescription systems, information representing an expert's knowledge and skills would not be needed.
Thus,
Referring to
In this embodiment, implantable medical device 110 is a pacer that is operatively coupled to a patient's heart 204 by a pacing lead 206. The components of implantable medical device 110 include, for example, an atrial sense amplifier 208, a ventricular sense amplifier 210, an atrial stimulating circuit 212, a ventricular stimulating circuit 214, a controller 216, a memory 218, and an input/output (I/O) interface 220. Device 110 may also include other components that are known to people of ordinary skill in the art, such as an accelerometer (not shown) for measuring patient activity. The components of implantable medical device 110 are housed within an implantable housing (indicated by the broken lined box in
Atrial sense amplifier 208, ventricular sense amplifier 210, atrial stimulating circuit 212 and ventricular stimulating circuit 214 are operatively coupled to pacing lead 206 via a pair of conductors 222. Pacing lead 206 includes an atrial sensing electrode 224 and atrial stimulating electrode 226 adapted to be disposed in the right atrial chamber of heart 204, and a ventricular sensing electrode 228 and ventricular stimulating electrode 230 adapted to be disposed in the right ventricular chamber of heart 204. Sensed atrial and ventricular electrical signals generated by sensing electrodes 224 and 228 are applied to atrial and ventricular sense amplifiers 208 and 210, respectively. Atrial and ventricular stimulating signals generated by atrial and ventricular stimulating circuits 212 and 214 are applied to atrial and ventricular stimulating electrodes 226 and 230, respectively. Atrial sense amplifier 208, ventricular sense amplifier 210, atrial stimulating circuit 212, and ventricular stimulating circuit 214, are also each operatively coupled to controller 216.
Controller 216 includes a micro-controller or microprocessor which is configured to execute a program stored in a read-only memory (ROM) portion of memory 218, and to read and write data to and from a random access memory (RAM) portion of memory 218. In one embodiment, memory 218 also includes an electrically-erasable programmable read only memory (EEPROM) portion that is used by the micro-controller or microprocessor for storing and retrieving one or more programmable parameters for the medical device. By executing the program stored in memory 218, controller 216 is configured to process the atrial and ventricular electrical signals from atrial and ventricular sense amplifiers 208 and 210, and to provide control signals to atrial and ventricular stimulating circuits 212 and 214. In response, stimulating circuits 212 and 214 provide stimulating pulses to heart 204 via atrial and ventricular stimulating electrodes 226 and 230 at appropriate times. In other embodiments, controller 216 may include other types of control logic elements or circuitry.
Implantable medical device 110 is capable of delivering therapy to the patient in a manner that depends on one or more parameters than can be programmed by the patient's physician or other medical practitioner using medical device programmer 106. For example, in one embodiment, device 110 is a pacer capable of delivering therapy to heart 204 that has one or more programmable parameters such as an atrioventricular (AV) delay, an LV offset, a target heart rate, whether or not to turn on rate smoothing, smoothing percentage for increasing rate, smoothing percentage for decreasing rate, etc. When any of these or other programmable parameters is downloaded to implantable medical device 110 from medical device programmer 106, controller 216 stores the received parameter value(s) in memory 218. Then, during operation of device 110, controller 216 reads the programmable parameters from memory 218, and uses those values to adjust the operations of device 110.
The implantable medical device shown in
Referring to
In this embodiment, medical device programmer 106 includes a processor 306 and a memory 308 coupled to processor 306 via a communications bus 310. By executing a program stored in memory 308, processor 306 is configured to perform the functions described herein. Programmer 106 also includes an implantable device interface 312, a network interface 314, a user input device interface 316, and a user output device interface 318, each of which is coupled to processor 306 via bus 310. Implantable device interface 312 is coupled to wand 302 to allow processor 306 to communicate with medical device 110. Network interface 314 is coupled to network 102 to allow processor 306 to communicate with central server 104. User input device interface 316 is coupled to one or more user input devices 320 to allow processor 306 to receive inputs from a user (e.g., medical practitioner). User input devices 320 include, for example, one or more of a keyboard, a keypad, a mouse, a touchscreen, a microphone and voice-recognition circuit, a light pen, etc. User output device interface 318 is coupled to one or more user output devices 322 to allow processor 306 to provide outputs to the user. User output devices 322 include, for example, a display, a touchscreen, a printer, a strip-chart recorder, a speaker, etc. In
Wand 302, and implantable device interface 312, allow programmer 106 to transmit one or more programmable parameters to implantable medical device 110. In addition, in one embodiment, wand 302 and interface 312 allow programmer 106 to receive signals from implantable medical device 110, such as signals representing one or more characteristics of the patient. For example, these signals could include, or be derived from, signals sensed by sensing electrodes 224 and 228 (
User input device(s) 320 allow users (e.g., medical practitioners) to input data and/or control operations of programmer 106. For example, where programmer 106 can program more than one type of medical device, a user can actuate an input device 320 to generate an input signal specifying the type of medical device being programmed. For another example, where central server 104 hosts both expert and custom prescription systems, a user can actuate an input device 320 to select between the expert and custom prescription systems. For another example, where central server 104 hosts multiple expert prescription systems, a user can actuate an input device 320 to generate an input signal selecting one of the expert prescription systems. For yet another example, where a user can input one or more patient characteristics, the user can actuate an input device 320 to generate input signals representing at least one characteristic of patient 304. In each case, data representing the input signals is communicated by programmer 106 to central server 104 via network 102 for use by central server 104 in prescribing one or more parameters for the medical device being programmed.
In one embodiment, programmer 106 also includes a patient monitoring system interface 324 that is also coupled to processor 306 via bus 310. Interface 324 is coupled to a patient monitoring system 326 to receive signals that represent at least one characteristic of patient 304. These signals are thus available to processor 306 via bus 310, and are communicated by processor 306 to central server 104 via network 102 for use by central server 104 in prescribing one or more parameters for the medical device being programmed. Patient monitoring system 326 can include, for example, a surface electrocardiograph (ECG) system having one or more sensing electrodes disposed on the patient's chest, or some other type of system for sensing or monitoring one or more characteristics of the patient 304.
In one embodiment, programmer 106 includes an interface 328 to a patient records computer system 330 that is also coupled to processor 306 via bus 310. Patient records computer system 330 stores patient records, such as the medical record of patient 304. Thus, processor 306 may access the medical records of patient 304, and communicate data from this medical record to central server 104 via network 102 for use by central server 104 in prescribing one or more parameters for the medical device being programmed. This data may include, for example, general patient data such as gender, age, etc. of patient 304, or more specific patient data such as the results of a particular diagnostic test. Interface 328 may, for example, include a local area network interface 328 for accessing patient records computer system 330 over a local area network. By providing access to the patient's record, the amount of data that needs to be manually input by the medical practitioner may be decreased. In one embodiment, the medical practitioner enters information identifying the patient into programmer 106 which is used in retrieving the medical record for that patient.
Thus, there are a number of ways by which programmer 106 can gather one or more characteristics of patient 304 for transmittal to central server 104. The ways include having a medical practitioner manually enter data using input device(s) 320, receiving data from implantable medical device 110, receiving data from patient monitoring system 326, and/or receiving data from patient records computer system 330. In any event, the one or more characteristics of patient 304 are communicated to central server 104 via network 102 for use in prescribing one or more parameters for programming the implantable medical device.
In one embodiment, medical device programmer 106 is similar to the ZOOM™ programmer available from the Guidant Corporation of Minnesota, except for the following differences: the addition of interface 314 to central server 104; the (optional) addition of interface 324 to patient monitoring system 326; the (optional) addition of interface 328 to patient records computer system 330; and the configuration (e.g., programming) of medical device programmer 106 to perform the functions described in the present application.
Referring to
In this embodiment, central server 104 includes a processor 404 along with a memory 406, a network interface 408, and a terminal interface 410, each coupled to processor 404. By executing a program stored in memory 406, processor 404 is configured to perform the functions described herein. Network interface 408 is coupled to network 102 to allow processor 404 to communicate with any of programmers 106 or expert clients 108. Terminal interface 410 is coupled to terminal 402 to allow processor 404 to communicate with system administrator terminal 402. In one embodiment, processor 404 is coupled to the other components 406, 408 and 410 of central server 104 via a communications bus (not shown).
Using network interface 408, processor 404 receives one or more characteristics of a patient from one of the medical device programmers 106 in centralized management system 100, and transmits at least one prescribed parameter back to that programmer 106 for use in programming an implantable medical device 110 coupled to that programmer 106. In various embodiments, network interface 408 is also involved in communicating other data between central server 104 and the programmer 106, such as signals input by a user to specify the type of medical device being programmed, to select whether to use an expert or custom prescription system, or to select which of multiple expert prescription systems to use. In one embodiment, using network interface 408, processor 404 also receives data from one or more expert clients 108 which is used for creating or updating one or more expert prescription systems stored in memory 406, in a manner that is further described below.
In the embodiment shown in
In the embodiment of
In another embodiment, any or all of the expert prescription systems is defined by a group of experts. For example, the manufacturer of a particular implantable medical device could define an expert prescription system for that device that combines the knowledge and skills of a team of experts who were involved in the development of that device. For another example, a team of experts could be assigned the task of working together to define an expert prescription system for a particular medical device. In each case, a medical practitioner using system 100 could then benefit from the combined knowledge and skills of the experts.
In the embodiment shown in
As described above, each “user” may be a single medical practitioner. In another embodiment, each “user” may include a group of medical practitioners who are associated with each other. For example, a single “user” may include two physicians who work closely together, and who use centralized management system 100 to share programming data. In this embodiment, the association of the practitioners is used to insure the quality of the custom prescription system. Practitioners not part of the association, however, are not allowed to use the custom prescription system since that system was not created by an expert.
Thus, in one embodiment, central server 104 includes or hosts a number of prescription systems, including one or more expert prescription systems and one or more custom prescription systems, that are selectable by a user to prescribe one or more programming parameters of a medical device based on at least one characteristic of a patient. The manner in which this selection occurs, in one embodiment, is illustrated in
Referring to
At 504, system 100 determines whether a custom prescription system is defined for the user. For example, if the user is authorized, central server 104 determines whether any of the custom prescription systems 414 stored in memory 406 is defined for that user, and communicates the result to programmer 106. If a custom prescription system 414 is defined for the user, the user is queried at 506 to determine whether to use that custom prescription system, or an expert prescription system. For example, the query is presented to the user using a user output device 322, and the user responds using a user input device 320. Note that the user is not given the choice of using any of the other custom prescription systems since these other systems were not defined by the user, or by an expert. At 508, system 100 determines whether the user wants to use the custom prescription system. If so, then at 510, system 100 selects the custom prescription system defined for that user to prescribe one or more parameters for an implantable medical device 110 being programmed by that user.
At 512, if the user wants to use an expert prescription system, or if a custom prescription system is not defined for the user, then system 100 queries the user to determine which expert to use. For example, central server 104 determines which expert prescription systems 412 are defined for the implantable medical device 110 being programmed, and communicates information about the respective experts to programmer 106 for presentation to the user using a user output device 322. The user selects which of the experts to use using a user input device 320. At 514, system 100 selects the expert prescription system based on the user's input. Thus, system 100 allows a user to select a custom prescription system defined for the user (if any), or to select one expert prescription system from a plurality of expert prescription systems. Central server 104 then uses the selected prescription system to prescribe the one or more parameters of the implantable medical device being programmed.
In another embodiment, central server 104 hosts a number of expert prescription systems, but does not host any custom prescription systems. In this embodiment, flow chart 500 is modified to eliminate 504, 506, 508 and 510. In another embodiment, central server 104 hosts a number of custom prescription systems, but does not host any expert prescription systems. In this embodiment, flow chart 500 is modified to eliminate 506, 512 and 514.
Referring to
The second column of table 602 identifies different classes of patients who may be implanted with the implantable medical device. For example,
Each attribute is typically a function of one or more of the patient characteristics that are communicated to central server 104 by programmer 106. For example, the function may include a determination of whether a particular characteristic is equal to a certain value (e.g., is the patient female?), is within a range of values (e.g., is the most recent measured intrinsic QRS width between 80 and 100 msec?), is less than a value (e.g., is the QRS width less than 80 msec?), is greater than a value (e.g., is the QRS width greater than 100 msec?), etc. The function may also include a function of two or more characteristics of the patient (e.g., is the patient female, and is the QRS width between 80 and 100 msec?). The attributes that make up a particular patient profile will be defined by the user. In one embodiment, programmer 106 and central server 104 cooperate to allow the user to create a patient profile (e.g., when the user selects this option on programmer 106), or to update an existing patient profile.
The fourth column of table 602 specifies a set of programming parameter(s) for the implantable medical device 110 being programmed for a class of patients who exhibit the patient profile for that class. For example, assume that Device A has three programming parameters designated Parameter 1, Parameter 2 and Parameter 3. For patients classified as belonging to Class I, the parameters for programming Device A are specified as Parameter 1=Data 1, Parameter 2=Data 2 and Parameter 3=Data 3. For patients classified as belonging to Class II, the parameters for programming Device A are specified as Parameter 1=Data 4, Parameter 2=Data 5 and Parameter 3=Data 6. Note that data values may be the same or different for any of the parameters (e.g., Data 1 may or may not equal Data 4).
In one embodiment, table 602 includes a fifth column for storing a patient identifier that uniquely identifies the user's patients who belong to the particular class of patients. For example, Andrew Adams and Bill Baxter have been classified as belonging to Class I for the purposes of programming Device A, while Charlie Carlson has been classified as belonging to Class II. Alternatively, another form of patient identifier (such as a patient identifier number) could be stored in this field. The patient identifier information may be used by a medical practitioner to help determine the classification of a particular patient. For example, a medical practitioner who is programming Device A for Doug Duncan and believes that Mr. Duncan's condition is similar to that of Mr. Adams may want to classify Mr. Duncan in the same class as Mr. Adams. In another embodiment, table 602 does include the fifth column.
Referring to
At 702, system 100 queries the user to determine what type of medical device 110 is being programmed. For example, in one embodiment, central server 104 transmits data identifying the types of medical devices specified in the first column of table 602 to programmer 106, and programmer 106 presents that data to the user on a user output device 322 and receives a signal selecting one of the device types from a user input device 320. In another embodiment, programmer 106 determines the type of medical device being programmed from a signal communicated to the programmer from the medical device. In another embodiment, system 100 only programs one type of device, and 702 is not needed.
At 704 and 706, system 100 presents patient class/patient profile information for the medical device being programmed to the user, and queries the user to select a patient class based upon which patient profile best matches the profile of the patient. For example, in one embodiment, the patient class/patient profile portion of table 602 is communicated from central server 104 to programmer 106, and programmer 106 presents that information to the user on a user output device 322 and receives a signal selecting one of the classes from a user input device 320. At 708, system 100 downloads the set of programming parameters for the selected patient class from central server 104 to programmer 106. At 710, system 100 presents that set to the user on a user output device 322. At 712 and 714, system 100 queries the user to determine if these programming parameters are acceptable. If not, system 100 allows the user to modify one or more of the parameters at 716, and then returns to 712 to determine if the parameters are acceptable. Once the parameters are acceptable, system 100 uses programmer 106 to program the implantable medical device 110 using the parameters.
At 720 and 722, system 100 queries the user to determine whether to update the user's custom prescription system. If not, the programming operation is complete. If so, system 100 updates the custom prescription system at 724. In one embodiment, system 100 allows the user to add an identifier for the current patient to the patient identifier field of the patient class that the current patient was determined as belonging to. In one embodiment, if any of the programming parameters was modified at 716, system 100 allows the user to define a new patient class that corresponds to the modified set of programming parameters. Once the custom prescription system is updated, the programming operation is complete.
The use of custom prescription systems may be particularly advantageous or convenient for medical practitioners who practice in multiple locations (e.g., at three or four different hospitals). By using system 100, such practitioners can store programming data in central server 104 where that data is always available regardless of where they are practicing.
In one embodiment, any or all of the expert prescription systems 412 is structured similarly to custom prescription systems 414, except that the person who defines and updates the expert prescription system 412 is an expert in the field. This expert can use one of expert clients 108, or can use a medical device programmer, to define or update the system 412.
In another embodiment, any or all of expert prescription systems 412 comprises an artificial intelligence (AI) engine. Referring to
Referring to
At 912, system 100 determines whether the patient might belong to more than a threshold number of possible classes. The threshold represents a reasonable number of possible classes that could be presented to the user to select from. In one embodiment, the threshold number is four, although other threshold numbers such as two, three, five, etc. could be used. If there are more than the threshold number of possible classes, system 100 returns to 902, so that additional data can be received from any or all of medical device 110, patient monitoring system 326, patient records computer system 330, and the user. Note that the user query set selected at 904 will often contain fewer questions for the user at this stage, since the user has already answered some questions and system 100 is now trying to narrow the number of possible patient classifications. This iterative process continues until system 100 narrows the number of possible classes to less than or equal to the threshold number.
At 914, system 100 determines whether there are more than one, but no more than the threshold number, of possible classes to which the patient might belong. If so, at 916, system 100 presents patient class/patient profile data for all of the possible classes to the user to give the user the opportunity to manually select from among these classes. For example, if the threshold number is four, then the user could be presented with two, three or four possible patient profiles. At 918, system 100 determines if the user wants to select one of the possible classes. The user can input his or her decision using a user input device 320. If not, system 100 returns to 902 to gather additional information in an attempt to further narrow the number of possible classes. If so, system 100 downloads the set of programming parameters for the selected class from central server 104 to programmer 106 at 922, queries the user to determine if these parameters are acceptable at 924 and 926, and programs the implantable medical device using the programming parameters if acceptable at 928. If the parameters are not acceptable, system 100 queries the user to determine if the user wants to try another prescription system at 930 and, if so, returns to the selection logic (
At 914, system 100 determines whether there is one and only one possible class to which the patient might belong. If so, system 100 performs the programming procedure of 922, 924, 926, 928, 930 described above. If, however, system 100 is unable to determine any possible classes to which the patient might belong, then the query “Patient classification not available. Try again?” is presented to the user at 932, and system 100 either allows the user to try another prescription system, or ends without programming the medical device.
In the embodiment of
In one embodiment, the administrator of system 100 contracts with a number of experts to define the expert prescription systems, and to update the expert prescription systems at predetermined intervals. For example, a particular expert may be given an obligation to update the expert prescription system that she created every six months. This will help to insure that the expert prescription systems reflect the current state of the art. Client systems 108 allow the experts to update their prescription systems conveniently. In one embodiment, each expert prescription system includes a “valid” flag which is set to an invalid state if the expert prescription system is not updated by the expert in a timely fashion, and system 100 prevents the selection of any expert prescription system which is not valid. By enlisting experts to create and update the expert prescription systems, the knowledge and skills of the experts can be leveraged by being made available to any users of system 100.
To update an expert prescription system, an expert may, for example, use the AI engine 802 to add a new rule to rule database 804, to delete a rule from rule database 804, or to modify a rule in rule database 804. For example, an expert may learn that it is important to determine another piece of information about a patient in order to prescribe a set of programming parameters, or may learn that another set of programming parameters provides improved therapy for a particular class of patient. By working with AI engine 802, the expert can change or update the rules in rule database 804 to reflect this new knowledge.
In one embodiment, central server 104 further includes a prescription verification system that is used to help insure that the custom and/or expert prescription systems are acceptable. In one embodiment, the prescription verification system includes a set of rules, or an AI system, that is used to evaluate a prescription system. For example, one of the rules could be that a pacemaker may not be set to operate in a monitoring mode only. Generally, these rules are designed to catch major problems in the definition of the prescription systems that would be obviously incorrect to a person of skill in the art, rather than trying to catch subtle errors. In one embodiment, if the prescription verification system finds a violation of any of the rules, system 100 attempts to alert the physician (e.g., by automatically paging or sending an email to the physician). In another embodiment, system 100 does not allow the user or expert to define or update the prescription system if a rule violation is detected. In another embodiment, system 100 informs the user or expert when a rule violation is detected, and requests confirmation from the user or expert before modifying the prescription system.
The above description and the accompanying drawings are intended to be illustrative, and not restrictive. Many other embodiments will be apparent to those of ordinary skill in the art upon reviewing the above description. For example, while the above description concentrates on the programming of implantable medical devices, system 100 may be used for programming non-implantable medical devices. Also, while some of the functions of system 100 are described as being performed by a medical device programmer, the central server or an expert client, it should be understood that the distribution of the functions within system 100 can be modified as would be apparent to a person of skill in the art. Further, while this application describes particular embodiments of the custom prescription systems and expert prescription systems, it should be understood that these prescription systems can be defined in a number of different ways by the users and by the experts. For example, a user could also use an expert system to help define his or her custom prescription system. The scope of the present invention should therefore be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.
This application is a continuation of U.S. patent application Ser. No. 10/008,354 (U.S. Patent Application No. 20030088290A1), filed Nov. 7, 2001, now issued as U.S. Pat. No. 7,383,088, commonly assigned and incorporated herewith in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4494950 | Fischell | Jan 1985 | A |
4712179 | Heimer | Dec 1987 | A |
4777960 | Berger et al. | Oct 1988 | A |
4809697 | Causey, III et al. | Mar 1989 | A |
4825869 | Sasmor et al. | May 1989 | A |
4886064 | Strandberg | Dec 1989 | A |
4928688 | Mower | May 1990 | A |
4967749 | Cohen | Nov 1990 | A |
4987897 | Funke | Jan 1991 | A |
5031629 | DeMarzo | Jul 1991 | A |
5047930 | Martens et al. | Sep 1991 | A |
5097831 | Lekholm | Mar 1992 | A |
5113869 | Nappholz et al. | May 1992 | A |
5174289 | Cohen | Dec 1992 | A |
5226413 | Bennett et al. | Jul 1993 | A |
5251626 | Nickolls et al. | Oct 1993 | A |
5262944 | Weisner et al. | Nov 1993 | A |
5267560 | Cohen | Dec 1993 | A |
5282838 | Hauser et al. | Feb 1994 | A |
5292341 | Snell | Mar 1994 | A |
5309919 | Snell et al. | May 1994 | A |
5311873 | Savard et al. | May 1994 | A |
5321618 | Gessman | Jun 1994 | A |
5372607 | Stone et al. | Dec 1994 | A |
5421830 | Epstein et al. | Jun 1995 | A |
5431691 | Snell et al. | Jul 1995 | A |
5441047 | David et al. | Aug 1995 | A |
5507782 | Kieval et al. | Apr 1996 | A |
5540727 | Tockman et al. | Jul 1996 | A |
5549654 | Powell | Aug 1996 | A |
5576952 | Stutman et al. | Nov 1996 | A |
5594638 | Iliff | Jan 1997 | A |
5607460 | Kroll et al. | Mar 1997 | A |
5613495 | Mills et al. | Mar 1997 | A |
5626630 | Markowitz et al. | May 1997 | A |
5630835 | Brownlee | May 1997 | A |
5666487 | Goodman et al. | Sep 1997 | A |
5690690 | Nappholz et al. | Nov 1997 | A |
5693076 | Kaemmerer | Dec 1997 | A |
5697959 | Poore | Dec 1997 | A |
5716382 | Snell | Feb 1998 | A |
5720771 | Snell | Feb 1998 | A |
5722999 | Snell | Mar 1998 | A |
5724985 | Snell et al. | Mar 1998 | A |
5731296 | Sollevi | Mar 1998 | A |
5752976 | Duffin et al. | May 1998 | A |
5759199 | Snell et al. | Jun 1998 | A |
5792203 | Schroeppel | Aug 1998 | A |
5800473 | Faisandier | Sep 1998 | A |
5833623 | Mann et al. | Nov 1998 | A |
5860918 | Schradi et al. | Jan 1999 | A |
5891178 | Mann et al. | Apr 1999 | A |
5911132 | Sloane et al. | Jun 1999 | A |
5935078 | Feierbach | Aug 1999 | A |
5935081 | Kadhiresan | Aug 1999 | A |
5987519 | Peifer et al. | Nov 1999 | A |
6001060 | Churchill et al. | Dec 1999 | A |
6015388 | Sackner et al. | Jan 2000 | A |
6016442 | Hsu et al. | Jan 2000 | A |
6016447 | Juran et al. | Jan 2000 | A |
6045513 | Stone et al. | Apr 2000 | A |
6070101 | Struble et al. | May 2000 | A |
6076015 | Hartley et al. | Jun 2000 | A |
6081786 | Barry et al. | Jun 2000 | A |
6091990 | Hsu et al. | Jul 2000 | A |
6093146 | Filangeri | Jul 2000 | A |
6102874 | Stone et al. | Aug 2000 | A |
6112224 | Peifer et al. | Aug 2000 | A |
6141586 | Mower | Oct 2000 | A |
6148234 | Struble | Nov 2000 | A |
6168563 | Brown | Jan 2001 | B1 |
6190324 | Kieval et al. | Feb 2001 | B1 |
6240317 | Villaseca et al. | May 2001 | B1 |
6249705 | Snell | Jun 2001 | B1 |
6250309 | Krichen et al. | Jun 2001 | B1 |
6272377 | Sweeney et al. | Aug 2001 | B1 |
6275727 | Hopper et al. | Aug 2001 | B1 |
6280389 | Ding et al. | Aug 2001 | B1 |
6280409 | Stone et al. | Aug 2001 | B1 |
6285907 | Kramer et al. | Sep 2001 | B1 |
6304773 | Taylor et al. | Oct 2001 | B1 |
6336900 | Alleckson et al. | Jan 2002 | B1 |
6336903 | Bardy | Jan 2002 | B1 |
6351675 | Tholen et al. | Feb 2002 | B1 |
6363282 | Nichols et al. | Mar 2002 | B1 |
6368284 | Bardy | Apr 2002 | B1 |
6370427 | Alt et al. | Apr 2002 | B1 |
6383136 | Jordan | May 2002 | B1 |
6398728 | Bardy | Jun 2002 | B1 |
6400982 | Sweeney et al. | Jun 2002 | B2 |
6411840 | Bardy | Jun 2002 | B1 |
6411847 | Mower | Jun 2002 | B1 |
6438407 | Ousdigian et al. | Aug 2002 | B1 |
6438408 | Mulligan et al. | Aug 2002 | B1 |
6440066 | Bardy | Aug 2002 | B1 |
6441747 | Khair et al. | Aug 2002 | B1 |
6442432 | Lee | Aug 2002 | B2 |
6442433 | Linberg | Aug 2002 | B1 |
6443890 | Schulze et al. | Sep 2002 | B1 |
6453201 | Daum et al. | Sep 2002 | B1 |
6480745 | Nelson et al. | Nov 2002 | B2 |
6497655 | Linberg et al. | Dec 2002 | B1 |
6526313 | Sweeney et al. | Feb 2003 | B2 |
6542775 | Ding et al. | Apr 2003 | B2 |
RE38119 | Mower | May 2003 | E |
6564104 | Nelson et al. | May 2003 | B2 |
6564105 | Starkweather et al. | May 2003 | B2 |
6585644 | Lebel et al. | Jul 2003 | B2 |
6622040 | Ding et al. | Sep 2003 | B2 |
6622045 | Snell et al. | Sep 2003 | B2 |
6648823 | Thompson et al. | Nov 2003 | B2 |
6650939 | Taepke, II et al. | Nov 2003 | B2 |
6650944 | Goedeke et al. | Nov 2003 | B2 |
6665558 | Kalgren et al. | Dec 2003 | B2 |
6668194 | VanHout | Dec 2003 | B2 |
6669631 | Norris et al. | Dec 2003 | B2 |
6684103 | Ding et al. | Jan 2004 | B2 |
6687547 | Goedeke et al. | Feb 2004 | B2 |
6735479 | Fabian et al. | May 2004 | B2 |
6738667 | Deno et al. | May 2004 | B2 |
6738671 | Christophersom et al. | May 2004 | B2 |
6804558 | Haller et al. | Oct 2004 | B2 |
6811537 | Bardy | Nov 2004 | B2 |
6878112 | Linberg et al. | Apr 2005 | B2 |
6961617 | Snell | Nov 2005 | B1 |
6999815 | Ding et al. | Feb 2006 | B2 |
7043305 | Kenknight et al. | May 2006 | B2 |
7070562 | Bardy | Jul 2006 | B2 |
7136707 | Hall et al. | Nov 2006 | B2 |
7181285 | Lindh et al. | Feb 2007 | B2 |
7383088 | Spinelli et al. | Jun 2008 | B2 |
7546162 | Ding et al. | Jun 2009 | B2 |
7899534 | Lindh et al. | Mar 2011 | B2 |
8099165 | Lindh et al. | Jan 2012 | B2 |
20010007053 | Bardy | Jul 2001 | A1 |
20010012955 | Goedeke et al. | Aug 2001 | A1 |
20010031997 | Lee | Oct 2001 | A1 |
20010031998 | Nelson et al. | Oct 2001 | A1 |
20010039375 | Lee et al. | Nov 2001 | A1 |
20010039503 | Chan et al. | Nov 2001 | A1 |
20010047125 | Quy | Nov 2001 | A1 |
20010049544 | Lee | Dec 2001 | A1 |
20020013613 | Haller et al. | Jan 2002 | A1 |
20020016550 | Sweeney et al. | Feb 2002 | A1 |
20020019586 | Teller et al. | Feb 2002 | A1 |
20020023654 | Webb | Feb 2002 | A1 |
20020026103 | Norris et al. | Feb 2002 | A1 |
20020026223 | Riff et al. | Feb 2002 | A1 |
20020049482 | Fabian et al. | Apr 2002 | A1 |
20020052539 | Haller et al. | May 2002 | A1 |
20020082868 | Pories et al. | Jun 2002 | A1 |
20020115939 | Mulligan et al. | Aug 2002 | A1 |
20020120311 | Lindh et al. | Aug 2002 | A1 |
20020123672 | Christophersom et al. | Sep 2002 | A1 |
20020138012 | Hodges et al. | Sep 2002 | A1 |
20020193667 | McNair | Dec 2002 | A1 |
20030050803 | Marchosky | Mar 2003 | A1 |
20030074029 | Deno et al. | Apr 2003 | A1 |
20030088290 | Spinelli et al. | May 2003 | A1 |
20030144702 | Yu et al. | Jul 2003 | A1 |
20030144703 | Yu et al. | Jul 2003 | A1 |
20030144711 | Pless et al. | Jul 2003 | A1 |
20030171791 | KenKnight et al. | Sep 2003 | A1 |
20040117204 | Mazar et al. | Jun 2004 | A1 |
20040122294 | Hatlestad et al. | Jun 2004 | A1 |
20040122295 | Hatlestad et al. | Jun 2004 | A1 |
20040122296 | Hatlestad et al. | Jun 2004 | A1 |
20040122297 | Stahmann et al. | Jun 2004 | A1 |
20040122484 | Hatlestad et al. | Jun 2004 | A1 |
20040122485 | Stahmann et al. | Jun 2004 | A1 |
20040122486 | Stahmann et al. | Jun 2004 | A1 |
20040122487 | Hatlestad et al. | Jun 2004 | A1 |
20040133080 | Mazar | Jul 2004 | A1 |
20040133246 | Ding et al. | Jul 2004 | A1 |
20040143304 | Hall et al. | Jul 2004 | A1 |
20040230456 | Lozier et al. | Nov 2004 | A1 |
20060195163 | KenKnight et al. | Aug 2006 | A1 |
20110137368 | Lindh et al. | Jun 2011 | A1 |
20120083854 | Lindh et al. | Apr 2012 | A1 |
Number | Date | Country |
---|---|---|
0297675 | Jan 1989 | EP |
0709058 | May 1996 | EP |
10066698 | Jan 2001 | EP |
WO-9914882 | Mar 1999 | WO |
WO-0041765 | Jul 2000 | WO |
WO-0041766 | Jul 2000 | WO |
WO-0103575 | Jan 2001 | WO |
WO-0124876 | Apr 2001 | WO |
WO-0167948 | Sep 2001 | WO |
WO-2004104901 | Dec 2004 | WO |
Entry |
---|
“U.S. Appl. No. 10/008,354, Notice of Allowance mailed Jan. 23, 2008”, 4 pgs. |
“U.S. Appl. No. 11/624,035 Notice of Allowance mailed Oct. 25, 2010”, 9 pgs. |
US 6,527,714, 3/2003, Bardy (withdrawn). |
“U.S. Appl. No. 09/748,791 Advisory Action mailed Aug. 4, 2004”, 3 pgs. |
“U.S. Appl. No. 09/748,791 Final Office Action mailed Mar. 9, 2004”, 6 pgs. |
“U.S. Appl. No. 09/748,791 Final Office Action mailed Aug. 23, 2005”, 6 pgs. |
“U.S. Appl. No. 09/748,791 Non Final Office Action mailed Feb. 3, 2005”, 8 pgs. |
“U.S. Appl. No. 09/748,791 Non Final Office Action mailed Feb. 10, 2006”, 11 pgs. |
“U.S. Appl. No. 09/748,791 Non Final Office Action mailed Feb. 21, 2003”, 9 pgs. |
“U.S. Appl. No. 09/748,791 Non Final Office Action mailed Aug. 28, 2002”, 9 pgs. |
“U.S. Appl. No. 09/748,791 Non Final Office Action mailed Sep. 17, 2003”, 8 pgs. |
“U.S. Appl. No. 09/748,791 Preliminary Amendment filed Feb. 21, 2001”, 2 pgs. |
“U.S. Appl. No. 09/748,791 Response filed May 10, 2006 to Non Final Office Action mailed Feb. 10, 2006”, 8 pgs. |
“U.S. Appl. No. 09/748,791 Response filed Jul. 5, 2005 to Non Final Office Action mailed Feb. 3, 2005”, 7 pgs. |
“U.S. Appl. No. 09/748,791 Response filed Jul. 9, 2004 to Final Office Action mailed Mar. 9, 2004”, 11 pgs. |
“U.S. Appl. No. 09/748,791 Response filed Jul. 21, 2003 to Non Final Office Action mailed Feb. 21, 2003”, 12 pgs. |
“U.S. Appl. No. 09/748,791 Response filed Nov. 23, 2005 to Final Office Action mailed Aug. 23, 2005”, 7 pgs. |
“U.S. Appl. No. 09/748,791 Response filed Nov. 25, 2002 to Non Final Office Action mailed Aug. 28, 2002”, 7 pgs. |
“U.S. Appl. No. 09/748,791 Response filed Dec. 17, 2003 to Non Final Office Action mailed Sep. 17, 2003”, 10 pgs. |
“U.S. Appl. No. 10/008,354 Final office action mailed Jul. 12, 2006”, 19 pgs. |
“U.S. Appl. No. 10/008,354 Final office action mailed Jul. 19, 2007”, FOAR,9 pgs. |
“U.S. Appl. No. 10/008,354 Non Final office action mailed Apr. 20, 2005”, 13 pgs. |
“U.S. Appl. No. 10/008,354 Non Final office action mailed Jul. 1, 2004”, 5 pgs. |
“U.S. Appl. No. 10/008,354 Non Final office action mailed Sep. 27, 2006”, 8 pgs. |
“U.S. Appl. No. 10/008,354 Non Final office action mailed Dec. 19, 2005”, 14 pgs. |
“U.S. Appl. No. 10/008,354 Response filed Jan. 3, 2005 to Non Final office action mailed Jul. 1, 2004”, 13 pgs. |
“U.S. Appl. No. 10/008,354 Response filed Feb. 27, 2007 to Non Final office action mailed Sep. 27, 2006”, 17 pgs. |
“U.S. Appl. No. 10/008,354 Response filed Mar. 20, 2006 to Non Final office action mailed Dec. 19, 2005”, 13 pgs. |
“U.S. Appl. No. 10/008,354 Response filed Aug. 30, 2005 to Non Final office action mailed Apr. 20, 2005”, 12 pgs. |
“U.S. Appl. No. 10/008,354 Response filed Sep. 12, 2006 to Final office action mailed Jul. 12, 2006”, 13 pgs. |
“U.S. Appl. No. 10/008,354, Response filed Sep. 19, 2007 to Final Office Action mailed Jul. 19, 2007”, 15 pgs. |
“Notice of Allowance Mailed Sep. 28, 2007 in U.S. Appl. No. 10/008,354”, 4 pgs. |
Barbaro, V. , et al., “A portable unit for remote monitoring of pacemaker patients”, Journal of Telemedicine and Telecare, 3(2), (1997),96-102. |
Bourge, Robert , et al., “Noninvasive Rejection Monitoring of Cardiac Transplants Using High Resolution Intramyocardial Electrograms”, PACE, vol. 21, Part II, (Nov. 1998),2338-2344. |
Girouard, Steven D., et al., “Cardiac Rhythm Management Systems and Methods Predicting Congestive Heart Failure Status”, Application Filed: Aug. 6, 2002 U.S. Appl. No. 10/213,268, 33 pgs. |
Hall, Jeffrey A., et al., “Recordable Macros for Pacemaker Follow-Up”, U.S. Appl. No. 10/348,191, filed Jan. 21, 2003, 17 pgs. |
Hatlestad, John , “Methods and Devices for Detection of Context When Addressing a Medical Condition of a Patient”, Application Filed: Oct. 11, 2002 U.S. Appl. No. 10/269,611, CPI Reference No. 01-173,29 pages. |
Hutten, H. , et al., “Cardiac pacemaker as bridge to cardiac telemonitoring”, Biomedizinische Technik, 41(6), Institut for Elektro-und Biomedizinische Technik Technische Universitat Graz., [Article in German With English Abstract],(Jun. 1996),158-165. |
Hutten, H. , et al., “Cardiac Telemonitoring through the Linkage of Close-up Telemetry and Internet Transmission”, Institute for Electro-and Biomedical Technology, Technical University of Graz Inffeldgasse, 42, [Article in German with English Abstract],(1997),67-69. |
Ji, J. , “An Ultraminiature CMOS Pressure Sensor for a Multiplexed Cardiovascular Catheter”, IEEE Transactions on Electron Devices, vol. 39, No. 10, (Oct. 1992),pp. 2260-2267. |
Kenknight, Bruce H., et al., “Method and Apparatus for Establishing Context Among Events and Optimizing Implanted Medical Device Performance”, Date Filed: Mar. 6, 2002 U.S. Appl. No. 10/093,353, 43 pgs. |
Kenknight, Bruce H., “Method and Apparatus for Establishing Context Among Events and Optimizing Implanted Medical Device Performance”, U.S. Appl. No. 11/381,051, filed May 1, 2006, 44 Pages. |
Lercher, P. , et al., “The Impact of the Multicenter Automatic Defibrillator Implantation Trial II in a University Hospital: Do all Patients with Myocardial Infarction and Reduced Left Ventricular Function need an Implantable Cardioverter-Defibrillator?”, Wiener Klinische Wochenschrift, 115 (5-6), Abstract in English, (Mar. 31, 2003),167-174. |
Lozier, Luke R., et al., “System for Identifying Candidates for ICD Implantation”, U.S. Appl. No. 10/438,261, filed May 14, 2003, 15 pgs. |
Moss, A. J., et al., “MADIT-II: Substudies and Their Implications”, Cardiac Electrophysiology Review, 7 (4), (Dec. 2003),430-433. |
Moss, A. J., et al., “Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction”, The New England Journal of Medicine, 346 (12), (Mar. 21, 2002),877-883. |
Mower, Morton , U.S. Appl. No. 10/214,474, filed Aug. 8, 2002, entitled “Method and Apparatus for Treating Hemodynamic Disfunction”, 3. |
Nelson, Chester G., et al., “Dynamic Bandwidth Monitor and Adjuster for Remote Communications with a Medical Device”, U.S. Appl. No. 60/173,083, filed Dec. 24, 1999, 12 pgs. |
Smith, R.A. , et al., “An intranet database for pacemaker patients”, International Journal of Medical Informatics, 47, (1997),79-82. |
Zhu, Qingsheng , et al., “Method and Apparatus for Determining Changes in Heart Failure Status”, Application Filed: Nov. 15, 2001 U.S. Appl. No. 10/001,223, 22 pgs. |
“U.S. Appl. No. 13/027,681, Non-Final Office Action mailed May 26, 2011”, 8 pgs. |
“U.S. Appl. No. 13/027,681, Response filed Aug. 26, 2011 to Non-Final Office Action mailed May 26, 2011”, 13 pgs. |
“U.S. Appl. No. 13/027,681, Notice of Allowance mailed Sep. 22, 2011”, 6 pgs. |
“Definition of Prescription”, Webster's Third New International Dictionary, (c) 2002 Merriam-Webster, (2002), p. 1792. |
Number | Date | Country | |
---|---|---|---|
20080077031 A1 | Mar 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10008354 | Nov 2001 | US |
Child | 11985995 | US |